AI Models Boost Diagnostic Accuracy
Discover how foundation models in medtech improve diagnostic accuracy and streamline clinical workflows for healthcare professionals.
Executive Brief
- The News: GE Healthcare promoted an MRI research foundation model
- Clinical Win: Foundation models detect diseases unseen during training
- Target Specialty: Radiologists using AI-enabled medical devices
Key Data at a Glance
Definition of Foundation Models: Trained on large datasets, process multiple types of data, tackle a wide variety of tasks
Key Characteristics: Unlabeled data, multiple data types, versatile tasks
First Version in Healthcare: Google's Med-PaLM in 2022
Year Term Coined: 2021 at Stanford
Year of Prominence at RSNA: 2023
AI Models Boost Diagnostic Accuracy
Editor’s note: This is the first story in a two-part series on the use of foundation models in the medtech industry. The second story will be published on Tuesday.
More medical device companies are promoting the use of “foundation models,” a type of artificial intelligence that can be adapted to a wide variety of tasks. However, there are still questions about use of the technology in the medtech industry.
In the past year, GE Healthcare promoted an MRI research foundation model, Philips announced plans to work with Nvidia to build a foundation model for MRIs, and several abstracts at last year's Radiological Society of North America meeting focused on how to assess and improve foundation models. The Food and Drug Administration also updated its database of AI-enabled medical devices to note that it is exploring ways to identify and tag devices that incorporate foundation models.
However, the definition of what counts as a foundation model is unclear, experts said, and it’s difficult to know if the tools available today are helping radiologists and patients.
What are foundation models?
Magdalini Paschali, a postdoctoral scholar at Stanford’s Department of Radiology, said foundation models have a few key characteristics: They’re trained on large datasets, which mostly consist of unlabeled data. They can process multiple types of data, such as images, text, medical history and genomics. And finally, they can tackle a wide variety of tasks, such as a model detecting a disease it hadn’t seen during training.
Paschali published a paper earlier this year in RSNA’s Radiology journal looking to define the technology more clearly.
In practice, “everything can really be defined as a foundation model,” said Akshay Chaudhari, an assistant professor of radiology and biomedical data science at Stanford.
Chaudhari said the term “foundation model” was first coined at Stanford in 2021. In healthcare, one of the first versions was the debut of Google’s Med-PaLM in late 2022, a large language model designed to answer medical questions.
Foundation models started becoming more prominent at RSNA in 2023, Chaudhari said.
Traditional deep learning models used in radiology, such as those for detecting pneumonia, are focused on a specific health condition and rely on labeled data. For example, radiologists would go through images, circling instances of pneumonia, or highlighting it in the text report, said Nina Kottler, associate chief medical officer for clinical artificial intelligence at Radiology Partners.
For foundation models, which are trained on millions of images instead of thousands of images, requiring labeled data simply isn’t practical, Chaudhari said.
Are foundation models more accurate?
Some medical device developers claim foundation models are more accurate than narrow AI models. For example, Aidoc, which makes triage software for radiology, says foundation models allow for faster development of more accurate AI tools.
Experts said the devices’ accuracy depends on how they’re built. Stanford’s Paschali said a foundation model used straight “out of the box,” without any specialization or additional training, may perform worse than a more specific AI tool, but it could work better once it has seen some examples and context.
“The best we can do is look at the summary statements that come from the FDA clearance documents, and at least on the market, we haven't really seen the benefits of these foundation models yet.”
Assistant professor of radiology and biomedical data science at Stanford
Because foundation models are trained on such a vast amount of data, they can perform better at finding rare events, such as brain aneurysms, Kottler said.
“When you only have a small number of people that have something, finding that thing is like a needle in a haystack,” Kottler said. “You need a very accurate model to be able to do that.”
Another area where foundation models can shine is allowing for faster development of other AI models. Building a traditional narrow AI model, it might take six months to clean the data, label the data and go through training, Kottler said. Different iterations of a foundation model can be built in a matter of weeks.
Clinical Perspective — Dr. Rohan Gupta, Dermatology
Workflow: As I incorporate foundation models into my practice, I'm adapting to their ability to process multiple types of data, such as images, text, and genomics. According to Magdalini Paschali, these models are trained on large datasets, mostly consisting of unlabeled data, which changes how I approach data analysis. I'm now considering how to leverage this capability to streamline my workflow.
Economics: The article doesn't address cost directly, but the fact that major companies like GE Healthcare and Philips are investing in foundation models suggests that there may be significant economic implications. As these models become more prevalent, I expect to see a shift in how resources are allocated to support their development and integration.
Patient Outcomes: While the article doesn't provide specific outcome data, the potential for foundation models to tackle a wide variety of tasks, such as detecting diseases they hadn't seen during training, is promising. For example, a model like Google's Med-PaLM, which can answer medical questions, may lead to more accurate diagnoses and improved patient care, although the exact benefits are still being explored.
Transparency & Corrections
HCP Connect is funded by Stravent LLC and maintains editorial independence from advertisers and pharmaceutical companies. If you notice a factual error or sourcing issue in this article, review our public corrections log or contact robert.foster@straventgroup.com.